课题基金 / 基金详情

CONTINUATION TRIAL OF LYMPHOSTAT-B ANTIBODY

CONTINUATION TRIAL OF LYMPHOSTAT-B ANTIBODY
淋巴细胞抑制物-B 抗体的继续试验
批准号:
7603678
负责人:
SUNG Sam LIM
金额:
$0.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

SUNG Sam LIM的其他基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a multi-center, open-label, continuation trial of LymphoStat-B in SLE subjects who achieved a satisfactory response in the Phase 2 study of LBSL02. Subjects will receive 10 mg/kg of LymphStat-B every 28 days intravenously over a period of 1 to 2 hours. The first infusion will be given over 2 hours. If no infusion reactions occur, then the 2nd dose will be infused over 1.5 hours. If no infusion reactions occur, then the 3rd and subsequent doses will be infused over 1 hour.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Georgians Organized Against Lupus: The GOAL of Better Understanding Social Determinants of Health in Lupus
  • 批准号:
    10553002
  • 项目类别:
  • 资助金额:
    $90.0万
  • 财政年份:
    2022
  • 负责人:
    SUNG Sam LIM
  • 依托单位:
Georgians Organized Against Lupus: The GOAL of Better Understanding Social Determinants of Health in Lupus
  • 批准号:
    10671599
  • 项目类别:
  • 资助金额:
    $90.0万
  • 财政年份:
    2022
  • 负责人:
    SUNG Sam LIM
  • 依托单位: